CH624415A5 - - Google Patents

Download PDF

Info

Publication number
CH624415A5
CH624415A5 CH965676A CH965676A CH624415A5 CH 624415 A5 CH624415 A5 CH 624415A5 CH 965676 A CH965676 A CH 965676A CH 965676 A CH965676 A CH 965676A CH 624415 A5 CH624415 A5 CH 624415A5
Authority
CH
Switzerland
Prior art keywords
general formula
ethoxy
mycobacterium
group
side chain
Prior art date
Application number
CH965676A
Other languages
German (de)
English (en)
Inventor
Ulrich Dr Eder
Gregor Dr Haffer
Gerhard Dr Sauer
Guenter Dr Neef
Rudolf Prof Wiechert
Alfred Dr Weber
Mario Dr Kennecke
Alfred Dr Popper
Rudolf Dr Mueller
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of CH624415A5 publication Critical patent/CH624415A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J13/00Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/005Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0011Androstane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0018Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0033Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0033Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/004Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0048Alkynyl derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005Ketals
    • C07J21/006Ketals at position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/0025Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16
    • C07J7/003Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00Preparation of steroids
    • C12P33/005Degradation of the lateral chains at position 17

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CH965676A 1975-08-01 1976-07-28 CH624415A5 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2534911A DE2534911C2 (de) 1975-08-01 1975-08-01 Verfahren zur Herstellung von 5-Androsten-17-on-Derivaten

Publications (1)

Publication Number Publication Date
CH624415A5 true CH624415A5 (es) 1981-07-31

Family

ID=5953265

Family Applications (1)

Application Number Title Priority Date Filing Date
CH965676A CH624415A5 (es) 1975-08-01 1976-07-28

Country Status (17)

Country Link
US (1) US4170518A (es)
JP (1) JPS5238090A (es)
AT (1) AT361639B (es)
BE (1) BE844745A (es)
CH (1) CH624415A5 (es)
CS (1) CS191981B2 (es)
DD (3) DD131562A5 (es)
DE (1) DE2534911C2 (es)
DK (1) DK140172C (es)
FR (1) FR2319650A1 (es)
GB (1) GB1576129A (es)
HU (1) HU183019B (es)
IE (1) IE44308B1 (es)
IT (1) IT1065955B (es)
NL (1) NL7608540A (es)
SE (1) SE420731B (es)
SU (1) SU697053A3 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2632677A1 (de) * 1976-07-16 1978-01-26 Schering Ag Verfahren zur herstellung von androstan-17-on-derivaten und deren verwendung
ES2261836T3 (es) * 1993-01-19 2006-11-16 Endorecherche Inc. Usos terapeuticos de dehidroepiandrosterona para tratamiento de libido disminuida y osteoporosis.
US5776923A (en) * 1993-01-19 1998-07-07 Endorecherche, Inc. Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone
WO1999007381A1 (en) * 1997-08-11 1999-02-18 Weider Nutrition International, Inc. Compositions and treatments to reduce side effects of administration of androgenic testosterone precursors
EP1149839A1 (en) * 2000-04-28 2001-10-31 AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A. Progesterone substantially free of delta14-pregnene-3,20-dione
KR100432054B1 (ko) * 2001-05-11 2004-05-17 (주)유진사이언스 스테롤로부터 4-안드로스텐-3,17-디온/안드로스타-1,4-디엔-3,17-디온으로의 뛰어난 전환능을 가지는 미생물 및 이의 제조방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3684657A (en) * 1970-05-11 1972-08-15 Searle & Co Selective microbiological degradation of steroidal 17-alkyls
US3759791A (en) * 1970-12-10 1973-09-18 Searle & Co Selective microbiological preparation of androst-4-ene-3,17-dione

Also Published As

Publication number Publication date
JPS6253160B2 (es) 1987-11-09
DD131561A5 (de) 1978-07-05
IE44308B1 (en) 1981-10-21
HU183019B (en) 1984-04-28
NL7608540A (nl) 1977-02-03
SU697053A3 (ru) 1979-11-05
FR2319650A1 (fr) 1977-02-25
DE2534911A1 (de) 1977-02-17
GB1576129A (en) 1980-10-01
DE2534911C2 (de) 1985-04-18
DK140172B (da) 1979-07-02
DK140172C (da) 1979-11-26
JPS5238090A (en) 1977-03-24
DK343976A (da) 1977-02-02
SE420731B (sv) 1981-10-26
US4170518A (en) 1979-10-09
FR2319650B1 (es) 1980-05-09
ATA565676A (de) 1980-08-15
IE44308L (en) 1977-02-01
BE844745A (fr) 1977-01-31
DD127114A5 (es) 1977-09-07
DD131562A5 (de) 1978-07-05
AT361639B (de) 1981-03-25
IT1065955B (it) 1985-03-04
CS191981B2 (en) 1979-07-31
SE7608575L (sv) 1977-02-02

Similar Documents

Publication Publication Date Title
DE2632677C2 (es)
DE2558088C2 (de) Verfahren zur Herstellung von 4-Androsten-3,17-dion-Derivaten
CH624415A5 (es)
EP0225892B1 (de) Verfahren zur herstellung von 4-androsten-3,17-dion und 1,4-androstadien-3,17-dion
EP0054810B1 (de) Verfahren zur Herstellung von 3-Oxo-delta-1,4-steroiden
EP0002535B1 (de) Verfahren zur Herstellung von 21-Hydroxy-20-methyl-pregnan-Derivaten
DE1904544C3 (de) Verfahren zur mikrobiologischen Umwandlung von 3 ß-Hydroxy-5,6- epoxysteroiden in 6-Hydroxy-3-KetoA<·4 -Steroide
DE2349023A1 (de) Neue d-homo-steroide
DE2558090C2 (de) Verfahren zur Herstellung von 4-Androsten-3,17-dion-Derivaten
CH625555A5 (es)
EP0227588B1 (de) Verfahren zur Herstellung von 4-Androsten-3, 17-dion und 1,4-Androstadien-3,17-dion
US3085088A (en) 16beta-alkoxysteroids and processes for producing the same
EP0496846A1 (de) Verfahren zur herstellung von 17-oxosteroiden.
DE2940285A1 (de) Verfahren zur herstellung von 11(alpha)-hydroxy-3-oxo-(delta)(pfeil hoch)1(pfeil hoch)(pfeil hoch),(pfeil hoch)(pfeil hoch)4(pfeil hoch)-steroiden
DE1182229B (de) Verfahren zur Herstellung von 7-Methylsteroiden
DE1139838B (de) Verfahren zur Herstellung von 6-Fluor-17ª‰-hydroxy-17ª‡-alkyl-1, 4-androstadien-3-onen
DE2919984A1 (de) 12 alpha -hydroxysteroide und deren herstellung

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased